We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Appili Therapeutics Inc | TSX:APLI | Toronto | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.035 | 0.035 | 0.04 | 0.035 | 0.035 | 0.035 | 112,923 | 20:04:32 |
TORONTO, Sept. 18, 2020 /CNW/ - Dr. Armand Balboni, CEO, Appili Therapeutics Inc. (TSX: APLI), joined his team and Sophie Van Houtte, Head, Company Services, TMX Group, to celebrate the company's graduation from TSX Venture Exchange to Toronto Stock Exchange and open the market.
Appili Therapeutics Inc. was founded to advance the global fight against infectious disease by matching clearly defined patient needs with drug development programs that provide solutions to existing challenges patients, doctors, and society face in this critical disease space. Appili has built a pipeline of assets designed to address a broad range of significant unmet medical needs in the infectious disease landscape, aiming to address some of the most urgent threats in global public health. For more information, please visit https://www.appilitherapeutics.com/
For Market Openings: Media may pick up a feed from the TOC (television operations centre) for all market open ceremonies. The feed is named TSX Transmit 1 (SD-SDI) and is produced at the TMX Broadcast Centre and sent live to the TOC. To pick up the feed via the Dejero network, please contact avservices@tmx.com. The client feature video will begin playing on the TMX media wall at approximately 9:27 a.m. ET and the markets will open with the sound of a siren at 9:30 a.m. ET
Date: Friday, September 18, 2020
Time: 9:00am - 9:30am
Place: Virtually Broadcast
SOURCE TMX Group Limited
Copyright 2020 Canada NewsWire
1 Year Appili Therapeutics Chart |
1 Month Appili Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions